Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2014 by Medical University of South Carolina.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00859131
First received: March 6, 2009
Last updated: February 28, 2014
Last verified: February 2014